Prospective Analysis of Hypersensitivity Reactions to Oxaliplatin

Clinical trial NCT00831571 · COMPLETED

Trial details

NCT number: NCT00831571
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Study type: OBSERVATIONAL

Colorectal Cancer Esophageal Cancer Gastric Cancer Small Bowel Cancer Pancreatic Cancer

Start date: 2009-02-01
Primary completion: 2012-12-01
Enrollment: 112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.